Forget Oral Wegovy: This Could Be a Bigger Win for Investors
The launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesThe launch of oral Wegovy marked a turning point for weight-loss drugs and stock investors. But a newer, rival oral G...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
Lam Research has quietly outpaced rivals in AI tooling, delivering triple-digit gains as 2026 guidance stays upbeat. ...
Joby Aviation reports modest quarterly revenue gains and robust cash reserves while advancing certification and inter...
The AI chip rally is shifting from training to real-world inference. This article explains why the next phase chip su...
Nebius Group delivered a blowout Q1 2026, with revenue growth of 684% and a high-stakes push from NVIDIA and Meta, tr...
U.S. healthcare equities rise as firms deploy agentic AI to cut labor costs, lifting a group of AI-enabled healthcare...
Investors eye Xcel Brands (XELB) 2026 as it reports Q1 results. This guide explains what to look for in the transcrip...
When Cerebras surged 68% on its first trading day, investors sat up and took notice. This piece breaks down what that...
Elastic faces a pivotal quarter as it closes 2026 with a cloud-first strategy. This article breaks down what to watch...
Space is shifting from science fiction to a real investment theme. This guide breaks down how the final frontier beco...
Nebius just announced a strategic partnership aimed at easing power bottlenecks in its AI infrastructure rollout. Thi...